rs219780
Orientation | minus |
Stabilized | minus |
Geno | Mag | Summary |
---|---|---|
(G;G) | 0 | common in complete genomics |
Make rs219780(A;A) |
Make rs219780(A;G) |
Reference | GRCh38 38.1/142 |
Chromosome | 21 |
Position | 36461009 |
Gene | CLDN14, LOC105369301 |
is a | snp |
is | mentioned by |
dbSNP | rs219780 |
dbSNP (classic) | rs219780 |
ClinGen | rs219780 |
ebi | rs219780 |
HLI | rs219780 |
Exac | rs219780 |
Gnomad | rs219780 |
Varsome | rs219780 |
LitVar | rs219780 |
Map | rs219780 |
PheGenI | rs219780 |
Biobank | rs219780 |
1000 genomes | rs219780 |
hgdp | rs219780 |
ensembl | rs219780 |
geneview | rs219780 |
scholar | rs219780 |
rs219780 | |
pharmgkb | rs219780 |
gwascentral | rs219780 |
openSNP | rs219780 |
23andMe | rs219780 |
SNPshot | rs219780 |
SNPdbe | rs219780 |
MSV3d | rs219780 |
GWAS Ctlg | rs219780 |
GMAF | 0.1515 |
Max Magnitude | 0 |
? | (A;A) (A;G) (G;G) | 28 |
---|---|---|
|
nature Carriers of two C alleles of this SNP in CLDN14 gene have 1.6 times higher risk of kidney stones. The rs219780(C;C) genotype is also associated with decreased bone mineral density. [PMID 19561606] Note that the risk genotype is the most common in all populations.
GWAS snp | |
---|---|
PMID | [PMID 19561606] |
Trait | Kidney stones |
Title | Sequence variants in the CLDN14 gene associate with kidney stones and bone mineral density |
Risk Allele | C |
P-val | 4E-12 |
Odds Ratio | 1.25 [1.17-1.33] |
[PMID 22396660] A Genome-Wide Association Study of Nephrolithiasis in the Japanese Population Identifies Novel Susceptible Loci at 5q35.3, 7p14.3, and 13q14.1
ClinVar | |
---|---|
Risk | rs219780(A;A) |
Alt | rs219780(A;A) |
Reference | Rs219780(G;G) |
Significance | Probable-non-pathogenic |
Disease | not specified Nonsyndromic Hearing Loss |
Variation | info |
Gene | CLDN14 |
CLNDBN | not specified Nonsyndromic Hearing Loss, Recessive |
Reversed | 1 |
HGVS | NC_000021.8:g.37833307C>T |
CLNSRC | ClinVar |
CLNACC | RCV000037064.3, RCV000353929.1, |
[PMID 26554238] Rs219780 SNP of Claudin 14 Gene is not Related to Clinical Expression in Primary Hyperparathyroidism
[PMID 33052825] Genetic polymorphisms in CLDN14 (rs219780) and ALP (rs1256328) genes are associated with risk of nephrolithiasis in Egyptian children.